cdaa has been researched along with gw9662 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, P; Peng, M; Ren, H; Sun, Z; Xiang, H; Xiao, J; Xu, J | 1 |
1 other study(ies) available for cdaa and gw9662
| Article | Year |
|---|---|
GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARĪ³/CD36 pathway and altering the gut microbiota.
Topics: Animals; Diet, High-Fat; Gastrointestinal Microbiome; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; PPAR gamma; RNA, Ribosomal, 16S | 2023 |